ABRJX Performance — Abr 50/50 Volatility Fund, Investor Shares
Data updated: 2026-09-29
ABRJX returned +6.26% year to date and +20.50% over one year to Jul 2026. Annualised returns are +10.70% over 3 years and +5.65% over 5 years. Against its Alternative category average the fund came out behind over three years but ahead over one: $100 invested three years ago grew to $136, against $168 for the category, and to $120 over one year, against $108. Volatility over the past three years was 23.26% a year. In the 12 months to Jul 2026 the fund lost a net $15.6M, and assets reached $28.25M.
ABRJX Growth of $100
What $100 invested in Abr 50/50 Volatility Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Alternative category average over the same months.
| Period | ABRJX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $120 | $108 |
| 3 years (Aug 2023 – Jul 2026) | $136 | $168 |
| 5 years (Aug 2021 – Jul 2026) | $132 | $159 |
| Since data start (Feb 2020 – Jul 2026) | $169 | $184 |
ABRJX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +6.26% |
| 1 year | +20.50% |
| 3 years (annualised) | +10.70% |
| 5 years (annualised) | +5.65% |
ABRJX Annual Returns
Calendar-year total returns of Abr 50/50 Volatility Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +6.26% |
| 2025 | +6.02% |
| 2024 | +13.71% |
| 2023 | +38.34% |
| 2022 | −34.30% |
| 2021 | +40.97% |
| 2020 (Feb–Dec) | +3.04% |
ABRJX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −0.3% | −1.0% | −13.3% | +13.8% | +5.2% | +2.7% | +1.0% | — | — | — | — | — |
| 2025 | +2.7% | −0.7% | −7.6% | −19.6% | +10.2% | +8.8% | +2.8% | +2.9% | +4.3% | +1.3% | +1.7% | +2.5% |
| 2024 | −0.3% | +1.8% | +1.8% | −3.4% | +4.3% | +2.7% | +1.0% | +1.7% | +1.8% | −7.7% | +14.2% | −3.5% |
| 2023 | +14.6% | −2.2% | −2.2% | +8.6% | +1.9% | +6.7% | +0.9% | −2.8% | −6.1% | −1.9% | +11.4% | +6.2% |
| 2022 | −10.8% | −8.9% | +0.5% | −15.2% | −6.0% | −10.1% | +14.1% | −2.5% | −11.5% | +7.3% | +9.4% | −2.8% |
| 2021 | −11.3% | +5.3% | +13.5% | +7.8% | +1.3% | +6.4% | +1.1% | +6.4% | −7.2% | +11.6% | −7.7% | +11.2% |
| 2020 | — | −10.8% | −6.4% | +5.1% | +10.0% | −21.6% | +13.0% | +5.8% | −6.3% | −10.0% | +33.8% | +1.0% |
ABRJX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 23.26%
- 3-year Sharpe ratio: 0.27 (vs 4.5% risk-free rate)
- Best month: +14.17% (Nov 2024)
- Worst month: −19.56% (Apr 2025)
ABRJX Fund Flows
Monthly money in and out of Abr 50/50 Volatility Fund, from SEC Form N-PORT.
- 12-month net flow: −$15.6M
- 12-month gross sales (incl. reinvestments): $5.5M
- Sales ÷ redemptions: 0.26×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $91K | $4.6M | −$4.5M |
| Jun 2026 | $590K | $4.1M | −$3.5M |
| May 2026 | $333K | $806K | −$472K |
| Apr 2026 | $620K | $1.6M | −$974K |
| Mar 2026 | $1.5M | $553K | $917K |
| Feb 2026 | $158K | $1.4M | −$1.2M |
| Jan 2026 | $464K | $1.9M | −$1.4M |
| Dec 2025 | $545K | $893K | −$349K |
| Nov 2025 | $386K | $1.8M | −$1.4M |
| Oct 2025 | $285K | $591K | −$306K |
| Sep 2025 | $236K | $1.5M | −$1.3M |
| Aug 2025 | $293K | $1.3M | −$1.0M |
ABRJX Assets Under Management
Net assets of Abr 50/50 Volatility Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $28.25M |
| 2026-04-30 | $33.85M |
| 2026-01-31 | $35.95M |
| 2025-10-31 | $37.96M |
| 2025-07-31 | $37.38M |
| 2025-04-30 | $35.85M |
| 2025-01-31 | $53.13M |
| 2024-10-31 | $48.82M |
| 2024-07-31 | $59.16M |
| 2024-04-30 | $54.96M |
| 2024-01-31 | $56.94M |
| 2023-10-31 | $51.96M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.